Heart Test Laboratories, Inc. (HSCS) Tops Q2 EPS by 136c

Heart Test Laboratories, Inc. (NASDAQ: HSCS) reported Q2 EPS of ($2.64), $1.36 better than the analyst estimate of ($4.00).

For earnings history and earnings-related data on Heart Test Laboratories, Inc. (HSCS) click here.

You May Also Be Interested In

• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Citi Upgrades Mercari, Inc (4385:JP) (MRCIF) to Buy
• Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy